Pantoprazole and Ozurdex drug interactions - a phase IV clinical study of FDA data


Drug interactions are reported among 24 people who take Pantoprazole and Ozurdex. Common interactions include colitis among females, and sinus node dysfunction among males.

The phase IV clinical study analyzes what interactions people who take Pantoprazole and Ozurdex have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 26, 2023

24 people who take Pantoprazole and Ozurdex together, and have interactions are studied.

What is Pantoprazole?

Pantoprazole has active ingredients of pantoprazole sodium. It is used in gastroesophageal reflux disease. Currently, eHealthMe is studying from 260,152 Pantoprazole users.

What is Ozurdex?

Ozurdex has active ingredients of dexamethasone. Currently, eHealthMe is studying from 2,294 Ozurdex users.

Number of Pantoprazole and Ozurdex reports submitted per year:

Pantoprazole and Ozurdex drug interactions.

Common Pantoprazole and Ozurdex drug interactions by gender *:


  1. Colitis
  2. Adverse event
  3. Atrophic vulvovaginitis
  4. Hypoalbuminaemia
  5. Impaired gastric emptying
  6. Thyroid mass
  7. Urinary incontinence
  8. Death


  1. Sinus node dysfunction
  2. Asthenia
  3. Drug ineffective
  4. Eye infection intraocular
  5. Retinal aneurysm
  6. Vitreous floaters
  7. Acute febrile neutrophilic dermatosis
  8. Cardiac disorder
  9. Complication of device insertion
  10. Endophthalmitis

Common Pantoprazole and Ozurdex drug interactions by age *:














  1. Asthenia
  2. Nausea
  3. Sinus node dysfunction
  4. Somnolence
  5. Syncope


  1. Blindness
  2. Disease progression
  3. Sinus node dysfunction
  4. Visual acuity reduced
  5. Drug ineffective
  6. Acute febrile neutrophilic dermatosis
  7. Cardiac disorder
  8. Endophthalmitis
  9. Lacrimal gland enlargement
  10. Loss of consciousness

Common conditions people have *:

  1. High Blood Pressure: 4 people, 16.67%
  2. Diabetic Retinopathy (damage to the retina caused by complications of diabetes): 3 people, 12.50%
  3. Diabetes: 3 people, 12.50%
  4. Acute Febrile Neutrophilic Dermatosis (skin disease characterized by the sudden onset of fever, leukocytosis, and tender): 3 people, 12.50%
  5. Uveitis (inflammation of the uvea): 2 people, 8.33%
  6. Sinusitis (inflammation of sinus): 2 people, 8.33%
  7. Macular Degeneration (painless eye condition that leads to the gradual loss of central vision): 2 people, 8.33%
  8. Diabetic Retinal Oedema (excessive build-up of fluid in the retina due to diabetes): 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Pantoprazole and Ozurdex?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

Drug side effects by duration, gender and age:

Common Pantoprazole drug interactions:

Browse interactions between Pantoprazole and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse interactions between Ozurdex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on pantoprazole sodium and dexamethasone (the active ingredients of Pantoprazole and Ozurdex, respectively), and Pantoprazole and Ozurdex (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Pantoprazole and Ozurdex.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: